Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320)

OBJECTIVE: To evaluate the effectiveness of drugs used to constrict patent ductus arteriosus (PDA) in newborns <28 weeks. METHODS: We performed a secondary analysis of the multi-center PDA-TOLERATE trial (NCT01958320). Infants with moderate-to-large PDAs were randomized 1:1 at 8.1±2.1 days to eit...

Descrición completa

Detalles Bibliográficos
Autores principales: Liebowitz, Melissa, Kaempf, Joseph, Erdeve, Omer, Bulbul, Ali, Håkansson, Stellan, Lindqvist, Johanna, Farooqi, Aijaz, Katheria, Anup, Sauberan, Jason, Singh, Jaideep, Nelson, Kelly, Wickremasinghe, Andrea, Dong, Lawrence, Hassinger, Denise C., Aucott, Susan W., Hayashi, Madoka, Heuchan, Anne Marie, Carey, William A., Derrick, Matthew, Wolf, Ilene Sue, Kimball, Amy, Sankar, Meera, Leone, Tina, Perez, Jorge, Serize, Arturo, Clyman, Ronald I.
Formato: Online Artigo Texto
Idioma:English
Publicado: 2019
Materias:
Article
Acceso en liña:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561645/
https://www.ncbi.nlm.nih.gov/pubmed/30850756
http://dx.doi.org/10.1038/s41372-019-0347-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561645/
https://www.ncbi.nlm.nih.gov/pubmed/30850756
http://dx.doi.org/10.1038/s41372-019-0347-4

Títulos similares